Esophageal varices are the major complication of portal hypertension. It is detected in about 50% of cirrhosis patients. Portal hypertensionis associated with both increased portal inflow and increased intrahepatic vascular resistance. Intrahepatic vascular resistance is caused by the architectural distortion of the liver resulting from fibrosis and by increased sinusoidal tone. Portal venous inflow results from a combination of ahyperdynamic circulatory state and increased plasma volume. In response to the increased portal pressure, collateral circulation develops by the opening of preexisting vascular channels. Esophagogastric varices are the most important collateral vessels: they tend to increase in size with the increase of portal pressure and rupture when wall tension exceeds a critical value.
Introduction
Portal hypertensionis a progressive condition of chronic liver disease and is a major cause of complications and death in patients with liver cirrhosis [1] .It is defined as hepatic venous pressure gradient (HVPG) of more than 5 mmHg [2].It indicates increased pressure in portal venous system. Normal portal venous pressure is 10 mmHg [3] ..Portal hypertension is associated with the most severe complications of cirrhosis, including ascites, hepatic encephalopathy, and bleeding from gastro-esophageal varices [4] . Esophageal variceal hemorrhage is a major complication of portal hypertension.
Initial mortality approximates 30% and 1 year after an index hemorrhage only 34% of patients are a1ive [5,6]. Both initial and longterm survival rates are inversely related to the severity of the underlying liver disease [6, 7] . Treatment of esophageal varices requires a clear understanding of the pathophysiology of portal hypertension. In this paper, we outline the current knowledge in the pathogenesis of portal hypertension andesophageal varices.
Pathogenesis of portal hypertension and esophageal varices Increased intrahepatic vascular resistance:
Intrahepatic endothelial dysfunction Cirrhosis is associated with evidence of endothelial dysfunction, both in the systemic circulation and within the liver [8, 9] 
